Processa Pharmaceuticals, Inc. (PCSA)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Condensed Consolidated Statements of Cash Flows (unaudited (P) | — |
|
| Consolidated Statements of Cash Flows (P) | ||
| Notes | ||
| Basis of Presentation and Summary of Significant Accounting Policies | — |
|
| Commitments and Contingencies | ||
| Concentration of Credit Risk | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Digital Assets | ||
| Digital Assets and Stablecoin Holdings | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | — |
|
| Leases | ||
| License Agreements | — |
|
| Litigation | — |
|
| Net Loss Per Share of Common Stock | ||
| Operating Leases | — |
|
| Option To License Pcs12852 | — |
|
| Organization | — |
|
| Organization and Summary of Significant Accounting Policies | — |
|
| Pay Vs Performance Disclosure | ||
| Pcs12852 | — |
|
| Related Party Transactions | ||
| Segment Reporting | ||
| Stock-based Compensation | ||
| Stockholders Equity | ||
| Subsequent Events | ||